Revenue increased 7.3%
Revenue changed +7.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +7.3% from the comparable as-filed period.
Capital expenditure changed -37.3% from the comparable as-filed period.
Operating margin changed -7 basis points from the comparable as-filed period.
Operating income changed +6.6% from the comparable as-filed period.
Gross margin changed -2 basis points from the comparable as-filed period.
Debt changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Inventory / revenue changed -85 basis points from the comparable as-filed period.
Inventory changed +5.1% from the comparable as-filed period.
Capex / revenue changed -27 basis points from the comparable as-filed period.
Selling, general & administrative changed +7.5% from the comparable as-filed period.
Gross profit changed +7.2% from the comparable as-filed period.
Net income changed -0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.